Literature DB >> 18094125

Simultaneous detection of Chlamydophila pneumoniae and Mycoplasma pneumoniae by use of molecular beacons in a duplex real-time PCR.

Karolina Gullsby1, Martin Storm, Kåre Bondeson.   

Abstract

A real-time PCR was designed for detection of Chlamydophila pneumoniae and Mycoplasma pneumoniae such that each pathogen could be detected in a single tube and differentiated using molecular beacons marked with different fluorochromes. This duplex PCR, targeting the P1 adhesion gene for M. pneumoniae and the ompA gene for C. pneumoniae, was compared with two conventional PCR assays targeting the 16S rRNA gene and the ompA gene. A total of 120 clinical throat and nasopharyngeal swab samples were tested. DNA extraction was performed using an alkali denaturation/neutralization method, and real-time amplification, detection, and data analysis were performed using a Rotor-Gene 2000 real-time rotary analyzer (Corbett Life Science, Sydney, Australia). Using conventional PCR as a reference in an analysis of 120 samples, 13 of 14 samples positive for C. pneumoniae were detected by the novel real-time PCR. In an analysis of M. pneumoniae, 22 samples were positive in the conventional PCR and the novel assay detected 24 positive samples. When using the conventional PCR as a reference, sensitivity and specificity were 93% and 100%, respectively, for C. pneumoniae and 100% and 98%, respectively, for M. pneumoniae. With an overall agreement of 98.8%, this suggests that performance of the new duplex real-time PCR is comparable to that of conventional PCR.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18094125      PMCID: PMC2238133          DOI: 10.1128/JCM.01540-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  39 in total

Review 1.  Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada).

Authors:  S F Dowell; R W Peeling; J Boman; G M Carlone; B S Fields; J Guarner; M R Hammerschlag; L A Jackson; C C Kuo; M Maass; T O Messmer; D F Talkington; M L Tondella; S R Zaki
Journal:  Clin Infect Dis       Date:  2001-07-20       Impact factor: 9.079

2.  Development of a multiplex real-time quantitative PCR assay to detect Chlamydia pneumoniae, Legionella pneumophila and Mycoplasma pneumoniae in respiratory tract secretions.

Authors:  Martine Welti; Katia Jaton; Martin Altwegg; Roland Sahli; Aline Wenger; Jacques Bille
Journal:  Diagn Microbiol Infect Dis       Date:  2003-02       Impact factor: 2.803

Review 3.  Background and current knowledge of Chlamydia pneumoniae and atherosclerosis.

Authors:  J T Grayston
Journal:  J Infect Dis       Date:  2000-06       Impact factor: 5.226

4.  Comparison of a new quantitative ompA-based real-Time PCR TaqMan assay for detection of Chlamydia pneumoniae DNA in respiratory specimens with four conventional PCR assays.

Authors:  Petra Apfalter; Wolfgang Barousch; Marion Nehr; Athanasios Makristathis; Birgit Willinger; Manfred Rotter; Alexander M Hirschl
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

5.  Detection of Mycoplasma pneumoniae in respiratory samples by real-time PCR using an inhibition control.

Authors:  Dominique Ursi; Kristien Dirven; Katherine Loens; Margareta Ieven; Herman Goossens
Journal:  J Microbiol Methods       Date:  2003-10       Impact factor: 2.363

6.  Chlamydia pneumoniae and myocarditis.

Authors:  H Gnarpe; J Gnarpe; B Gästrin; H Hallander
Journal:  Scand J Infect Dis Suppl       Date:  1997

7.  Chlamydia pneumoniae infection of brain cells: an in vitro study.

Authors:  Ellen Boelen; Harry W M Steinbusch; André J A M van der Ven; Gert Grauls; Cathrien A Bruggeman; Frank R M Stassen
Journal:  Neurobiol Aging       Date:  2006-04-18       Impact factor: 4.673

8.  Development and evaluation of real-time PCR-based fluorescence assays for detection of Chlamydia pneumoniae.

Authors:  Maria Lucia C Tondella; Deborah F Talkington; Brian P Holloway; Scott F Dowell; Karyn Cowley; Montse Soriano-Gabarro; Mitchell S Elkind; Barry S Fields
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

9.  Chlamydia pneumoniae is an important cause of community-acquired pneumonia in school-aged children: serological results of a prospective, population-based study.

Authors:  T Heiskanen-Kosma; M Korppi; A Laurila; C Jokinen; M Kleemola; P Saikku
Journal:  Scand J Infect Dis       Date:  1999

Review 10.  Multiplex polymerase chain reaction: a practical approach.

Authors:  P Markoulatos; N Siafakas; M Moncany
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

View more
  18 in total

1.  Comparison of commercial and in-house real-time PCR assays used for detection of Mycoplasma pneumoniae.

Authors:  Roger Dumke; Enno Jacobs
Journal:  J Clin Microbiol       Date:  2008-12-10       Impact factor: 5.948

2.  Evaluation of three real-time PCR assays for detection of Mycoplasma pneumoniae in an outbreak investigation.

Authors:  Jonas M Winchell; Kathleen A Thurman; Stephanie L Mitchell; W Lanier Thacker; Barry S Fields
Journal:  J Clin Microbiol       Date:  2008-07-09       Impact factor: 5.948

3.  Microfluidic platform versus conventional real-time polymerase chain reaction for the detection of Mycoplasma pneumoniae in respiratory specimens.

Authors:  Elizabeth Wulff-Burchfield; Wiley A Schell; Allen E Eckhardt; Michael G Pollack; Zhishan Hua; Jeremy L Rouse; Vamsee K Pamula; Vijay Srinivasan; Jonathan L Benton; Barbara D Alexander; David A Wilfret; Monica Kraft; Charles B Cairns; John R Perfect; Thomas G Mitchell
Journal:  Diagn Microbiol Infect Dis       Date:  2010-03-12       Impact factor: 2.803

4.  Detection of Mycoplasma pneumoniae in different respiratory specimens.

Authors:  Dan Xu; Shuxian Li; Zhimin Chen; Lizhong Du
Journal:  Eur J Pediatr       Date:  2010-11-24       Impact factor: 3.183

5.  Development and assessment of a multiplex real-time PCR assay for quantification of human immunodeficiency virus type 1 DNA.

Authors:  A Beloukas; D Paraskevis; C Haida; V Sypsa; A Hatzakis
Journal:  J Clin Microbiol       Date:  2009-05-06       Impact factor: 5.948

6.  The role of Mycoplasma in upper respiratory infections.

Authors:  Ken B Waites; T Prescott Atkinson
Journal:  Curr Infect Dis Rep       Date:  2009-05       Impact factor: 3.725

7.  Detection of Mycoplasma pneumoniae and Legionella pneumophila in Patients Having Community-Acquired Pneumonia: A Multicentric Study from New Delhi, India.

Authors:  Rama Chaudhry; Arvind Valavane; K Sreenath; Mamta Choudhary; Tanu Sagar; Trupti Shende; Mandira Varma-Basil; Srujana Mohanty; S K Kabra; A B Dey; Bhaskar Thakur
Journal:  Am J Trop Med Hyg       Date:  2017-09-21       Impact factor: 2.345

8.  Utility of serum procalcitonin values in patients with acute exacerbations of chronic obstructive pulmonary disease: a cautionary note.

Authors:  Ann R Falsey; Kenneth L Becker; Andrew J Swinburne; Eric S Nylen; Richard H Snider; Maria A Formica; Patricia A Hennessey; Mary M Criddle; Derick R Peterson; Edward E Walsh
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-02-23

9.  Recombinase Polymerase Amplification Combined with Real-Time Fluorescent Probe for Mycoplasma pneumoniae Detection.

Authors:  Tingting Jiang; Yacui Wang; Weiwei Jiao; Yiqin Song; Qing Zhao; Tianyi Wang; Jing Bi; Adong Shen
Journal:  J Clin Med       Date:  2022-03-23       Impact factor: 4.241

10.  Bacterial complications of respiratory tract viral illness: a comprehensive evaluation.

Authors:  Ann R Falsey; Kenneth L Becker; Andrew J Swinburne; Eric S Nylen; Maria A Formica; Patricia A Hennessey; Mary M Criddle; Derick R Peterson; Andrea Baran; Edward E Walsh
Journal:  J Infect Dis       Date:  2013-05-09       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.